Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Carcinoma in Situ 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Mastectomy, Subcutaneous × Clear all
NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed
450 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

Washington University School of Medicine

Phase 2 Completed
320 enrolled
Breast

Breast Neoplasms

NCT01002014 2022-04-21

Nipple Sparing Mastectomy - Cosmetic Outcomes

Wake Forest University Health Sciences

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms

NCT02061527 2018-04-24

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Karolinska University Hospital

Phase NA Completed
135 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡